NVNO (enVVeno Medical) Research & Development: $9.54 Mil (TTM As of Mar. 2026)


NVNO enVVeno Medical Corp NVNO
26 GF Score
Price $11.00
! 3 Warning Signs
View Full Analysis

What is enVVeno Medical Research & Development?

enVVeno Medical NVNO -3.25% 26 Research & Development is $9.54 Mil as of Mar. 2026. GuruFocus rates NVNO with a GF Score™ of 26/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. enVVeno Medical's Research & Development for the three months ended in Mar. 2026 was $2.11 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $9.54 Mil.

enVVeno Medical  (NAS:NVNO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

enVVeno Medical Research & Development Related Terms

enVVeno Medical Research & Development Historical Data

* Premium members only.

The historical data trend for enVVeno Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

enVVeno Medical Research & Development Chart

enVVeno Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.73 9.91 13.58 12.25 9.98

enVVeno Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.56 2.89 2.59 1.95 2.11
NVNO
26GF Score
enVVeno Medical Corp NVNO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

enVVeno Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $9.54 Mil mean?
enVVeno Medical (NVNO) has a Research & Development of $9.54 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on enVVeno Medical and its competitors.
Is enVVeno Medical's Research & Development too high?
enVVeno Medical's current Research & Development is $9.54 Mil. Overall, enVVeno Medical has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does enVVeno Medical's Research & Development compare to BMRA and STME?
enVVeno Medical's Research & Development of $9.54 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on enVVeno Medical and its competitors. enVVeno Medical's current Research & Development is $9.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is enVVeno Medical stock overvalued right now?
enVVeno Medical (NVNO) has a current Research & Development of $9.54 Mil. The current Research & Development is $9.54 Mil. enVVeno Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For enVVeno Medical (NVNO), the current Research & Development is $9.54 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

enVVeno Medical Business Description

Address 70 Doppler, Irvine, CA, USA, 92618
enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.
26GF Score

Get the complete analysis for NVNO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.00
Price